S80 7. Microbiology − Diagnosis and epidemiology Posters 123 A shotgun metaproteomics approach to study the faecal microbiome of patients with cystic fibrosis reveals a reduction of butyrate-producing bacteria
Objectives: Cultivation-independent analysis has revealed the polymicrobial nature of CF lung infection. The literature increasingly suggests that low sputum microbial diversity is associated with poor lung function in CF. The optimal means of profiling bacterial diversity in routine CF care is unknown. We assessed the suitability of a simple PCR-profiling tool, Ribosomal Intergenic Spacer Analysis (RISA), for the investigation of sputum bacterial diversity. Methods: Paired sputum samples were sent for routine microbiology and subjected to total nucleic acids extraction using an automated method applied in standard clinical virology. Microfluidics was used to separate RISA profiles amplified from this DNA. 16S rRNA gene pyrosequencing was performed on a subset of samples to evaluate the performance of RISA. Results: RISA profiles were successfully amplified from 200 sputum samples representative of 93 CF patients. 25% of these patients demonstrated RISA profiles dominated by one of the following Gram negative bacteria: Burkholderia cepacia complex, Ralstonia mannitolilytica, Stenotrophomonas maltophilia and Achromobacter xylosoxidans. Pyrosequencing analysis confirmed the loss of microbial diversity in these samples. In 9 cases conventional microbiology failed to correctly identify these dominant bacterial pathogens. The RISA profiles of UK CF patients infected with the B. cenocepacia ET12 strain matched those of Czech patients infected with the ST32 strain. Conclusions: Infection with non-fermentative Gram negative bacterial species leads to a loss in microbial diversity in CF that can be rapidly detected using a simple RISA profiling method.
Investigation of cystic fibrosis airway microbiome in patients
showing a severe decline in lung function and not responding to conventional antimicrobial therapy Objectives: The objectives of the present project are to assess the composition of airways microbiota in CF patients with a severe decline in lung function and not responding to antimicrobial therapy, and to discover new opportunistic (nonculturable) pathogens involved in pulmonary disease. Targeted antibiotic therapy against other members of the polymicrobial community can contribute to resolve pulmonary disease in CF patients. Methods: Three groups of CF patients were investigated: 1. normal lung function/mild decline (FEV 1 , >70% of predicted), 2. moderate lung dysfunction (FEV 1 , 40 to 69% of predicted) and 3. severe lung dysfunction (FEV 1 <40% predicted). Within each group, "non-responder" CF patients who have showed a severe decline in lung function (FEV1 5% in the last year) and did not respond to antimicrobial therapy, and "stable CF patients" (having had no change in pulmonary function or a rate decline in FEV1 equal to average value in the last year) has been enrolled. Composition of CF microbiota was investigated by using advanced culture-based methods and the molecular profiling method of Terminal Restriction Fragment Length Polymorphism (T-RFLP). Conclusion: Our preliminary findings suggest that combining culture-dependent and culture-independent approaches provides a more comprehensive perspective of CF microbiology than either approach alone. The results obtained will set the basis to identify new targets for treatment and management of bacterial infections in CF patients. This work was supported by the Italian Cystic Fibrosis Foundation (grant FFC#8/2012). 
